Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Neurology|May 1, 1995
The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosisL A Stone, J A Frank, P S Albert, et al.Neurology|June 1, 1995
Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and ageL A Stone, M E Smith, P S Albert, et al.Neurology|September 26, 1997
Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measureL A Stone, J A Frank, P S Albert, et al.Neurology|October 1, 1995
Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosisL A Stone, P S Albert, M E Smith, et al.Annals of Neurology|May 1, 1997
Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1bP A Calabresi, L R Tranquill, J M Dambrosia, et al.Annals of Neurology|May 1, 1993
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesionsM E Smith, L A Stone, P S Albert, et al.Neurology|June 9, 2004
Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effectsP W O'Connor, A Goodman, A J Willmer-Hulme, et al.Annals of Neurology|May 1, 1994
Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosisJ N Whitaker, P H Williams, B A Layton, et al.Pageof 3